Introduction
Dental plaque is an adherent bacterial biofilm that forms on hard and soft tissues intra-orally. [1] The mainstay in preventing periodontal disease is the control of dental plaque. While mechanical methods of plaque removal are considered as standard for individually applied oral diseases preventive practice,the higher prevalence of gingival diseases has prompted research into development of adjunctive methods for controlling oral biofilms. International Association for Dental Research (IADR) supports the benefit of oral rinsing with chemotherapeutics as an adjunct for controlling plaque and maintaining gingival health. [2] Various synthetic chemical agents have been evaluated over the years with respect to their antimicrobial activity in the oral cavity, but none are without shortcomings. Chlorhexidine digluconate, currently recognized as gold standard has its duration of use limited to just a few weeks because of undesirable side effects such as tooth discoloration, altered taste, and less commonly desquamation of oral mucosa. [3] Hence, the quest for a long term, ideal and a safe antiplaque and antigingivitis agent continues and this has also encouraged the search for alternative agents based on herbal extracts.
Many medicinal plants and their products are widely used for prevention and treatment of oral diseases, and among them Aloe vera extract can be one such oral hygiene aid which is naturally occurring, indigenous, cost effective with good therapeutic properties. Aloe vera is a cactus like plant, which is a member of Lilaceae family. The gel consists of 98-99% of water and remaining part comprises of pharmacological active compounds. Various uses of Aloe vera in dentistry can be found in literature owing to its multiple properties like anti-inflammatory, antibacterial, antiviral, pain relieving, wound healing, moisturizing and antioxidant potential . [4] [5] [6] On the basis of these researches, the aim of the present study was to evaluate the plaque inhibitory efficacy of Aloe vera mouthrinse in a four day de novo plaque accumulation model by a crossover study design and to compare it with benchmark antiplaque agent chlorhexidine.
II.
Materials and Methods
Study population
Fifteen student volunteers ( eight males and seven female students; age range from 19 to 25) participated in the study. The volunteers had a minimum of 25 scorable teeth and documented good standards of oral hygiene and gingival health [papilla bleeding index (PBI) of less than 30%]. The presence of grossly carious teeth, more than one full coverage restorations, fixed or removable orthodontic appliances, poor oral hygiene pocket depth > 5mm or attachment loss > 2mm, known intolerance or allergy to mouthrinses and use of antibiotics, medications or any other mouthwash in last three months that might interfere with plaque formation were the exclusion criteria.
All eligible volunteers were given an oral and written information about the purpose of the study and were asked to sign an informed consent. The study was conducted in accordance with ethical principles originating in the declaration of Helinski and consistent with clinical practice. The study protocol was approved by The Institutional Ethical Committee of Jamia Millia Islamia before commencing the study.
Test solutions
Test solution 1: Aloe vera mouthrinse (ALV): Two parts of commercially available 98 % pure Aloe vera juice (AVG Ltd.) was diluted with one part of distilled water (2:1). A colorant and flavouring agent was added to make it resemble to Chlorhexidine mouthrinse Test solution 2: Chlorhexidine mouthrinse (CHX; functional positive control): A commercially available nonalcoholic 0.2% Chlorhexidine mouthwash (Rexidin mouthwash; Indoco remedies Ltd.). Test solution 3: Placebo mouthrinse (PM; negative control): Distilled water. A colorant and flavouring agent was added to make it resemble to Chlorhexidine mouthrinse Study design A randomized, double blind, placebo-controlled and a three group crossover design was used for present clinical study. A total of 45 bottles were dispensed (15 of each mouthrinse) and each bottle was randomly assigned a number from 1 to 45. Randomization was performed by computer generated numbers. All the bottles were identically packed so that they could only be identified by numbers. Dispensing and allocation of mouthrinse was carried out by a person not directly involved in the `study.
Study included three experimental phases, each of a four day trial with a crossover interval of ten days in between each phase. All volunteers received one test rinse out of the three in each experimental phase according to an assigned random order of ALV, PM and CHX mouthrinse. In the first test phase, at baseline (Day one), all volunteers underwent an oral soft and hard tissue examination. Following this plaque was visualized using disclosing solution (2-TONE), and then a thorough scaling and polishing was performed to remove all plaque, stain and calculus, using ultrasonic scalers and hand instruments. To ensure that all deposits are removed a second episode of application of disclosing solution was carried out after which remaining plaque was removed. All normal oral hygiene procedures like brushing, flossing, inter dental brushes and consuming chewing gum were suspended for the next four days, and subjects were instructed to rinse two times a day, before breakfast and in the night for one minute with 10 ml of their assigned rinse. Along with each bottle of rinse, a 10 ml measure was given to facilitate the correct dosage. On Day five, the subjects were recalled along with their bottles so that their compliance can be assessed by measuring the residual mouthwash in them. All the subjects received a re-examination of their oral soft and hard tissue and were scored and photographed for assessment of plaque.
A washout period of ten days was instituted to exclude a carryover effect of the experimental mouthwash. During this time subjects resumed their oral hygiene procedures; following this washout period all volunteers again underwent a session of scaling in order to get plaque index to zero and protocol was repeated using the randomly assigned second test rinse. In a similar fashion third test phase was also carried where same volunteers used their assigned third experimental mouthrinse.
Clinical evaluation
The PBI by Saxer and Muhlemann was assessed at the buccal sites of the gingiva of all teeth on day one and day five as a control parameter to evaluate the gingival health of the subjects during the whole test period. [9] To test the influence of the experimental mouthrinses on plaque re-growth, clinical parameters recorded were plaque index (PI) according to Turesky et al. [7] modification of Quigley Hein PI [8] (6 point scale with scoring from 0 to 5) and plaque area (PA). For PI, the scores were taken at six surfaces per tooth: mesio-, mid-and disto-buccal, and mesio-, mid-,and disto-lingual after staining plaque with disclosing solution. All teeth except 3rd molars were examined, and all scorings were carried out by the same investigator who was unaware of the allocation of the mouthrinse to the participants. In addition, any adverse effects during the use of mouthrinses were recorded on a question sheet on a scale from absent, mildly, moderately or severely present.
Plaque area (PA) analysis
Plaque area was evaluated on day five by calculating the percentage of plaque-covered area to total tooth area. After staining with disclosing solution, digital standardized orthoradial photography and computerbased calculation were performed. For this study, only the upper right and left lateral incisors were selected. The stained buccal surface was highlighted on the digital photograph using the Adobe photoshop CS5 extended (12.1・3.2 version), and then the number of pixels within the area was calculated. In addition, the circumference of whole tooth surface was also highlighted and the number of pixels within this area was calculated. The relation between the plaque covered labial area (number of pixels) and the total vestibular labial tooth surface (number of pixels) gave the percentage of existing plaque. [10, 11] Statistical analysis After the test period was completed, the evaluation was performed using the computer program Statistical Package for Social Sciences (SPSS) Version 15.0 (SPSS Inc., Chicago, IL, USA) and Lead Tools_ 1991-2000 (LEAD Technologies Inc., Chicago, IL, USA).The mean values of clinical parameters (PI and PA) were calculated for each rinse solution. First analysis of variance (ANOVA) was performed to determine the differences among products tested. In the presence of significant differences, pair wise comparisons were made via Tukey HSD. The Tukey HSD was used as the post hoc test to control the possibility of alpha-error owing to smaller sample size. The confidence level of the study was kept at 95%; hence, a "P" value < 0.05 indicated statistically significant differences.
Results

Compliance
Three out of fifteen participants were dropped out of study as they did not follow mouthrinse regimen as instructed. Final analysis was based on observations from remaining twelve participants ( six males and six females). With the aid of questionnaire, it was observed that all the rinsing solutions were accepted by the participants, with report of no adverse side effects.
Plaque growth inhibition
The distribution of mean PI and PA of the three mouthrinses after four days of de novo plaque formation was statistically significant (P<0.001; Table 1 ).The positive control (CHX solution) attained the lowest value for plaque parameters (PI: 2.84, PA: 38.16%) while the highest was achieved by PM/negative control (PI: 3.83, PA: 58.68% ). Mean PI (3.48) and mean PA for ALV (51.42%) was in between the other two test rinses. Statistical significant difference (P<0.0001) in plaque parameters (PI and PA) was observed when CHX was compared to ALV and PM, and ALV to PM (Table 2) .
III. Discussion
The incorporation of broad spectrum antibacterial mouthrinses as an adjunct to patient"s daily oral hygiene regimens has assumed greater importance with the recognition that most individuals are unable to consistently maintain adequate levels of plaque alone using mechanical methods. [12] As the various synthetic antimicrobial agents are associated with adverse effects like tooth staining, taste alteration, immediate hypersensitivity, toxicity and increased resistance; alternative medicines may be developed from medicinal plants to replace synthetic drugs. The present study was undertaken to compare the plaque inhibitory potential of extract from a medicinal plant Aloe vera with a synthetic benchmark control 0.2% CHX. Additionally a negative control (PM/distilled water ) was added to enhance the quality of study.
Present study can be considered complying with the study design protocol for investigating the effect of mouthrinses stated by Lorenz et al. [10] As prospective randomized controlled clinical trials (RCT) provide a higher level of evidence for chemotherapeutic agents used for chemical plaque control, it was adopted in the current study. [13] The four day plaque re-growth crossover study design was chosen for the present endeavour as it has been employed in numerous investigations and can be described as an established method for assessing the plaque inhibitory activity of formulation per se and determines the relative efficacy of different formulations. [10, [14] [15] [16] [17] . The study design measures the plaque re-growth under the influence of test solution from a zero plaque baseline and avoids confounding influence of tooth brushing, which is highly variable in between individuals. If no plaque inhibition can be seen in this type of study, no further effect of rinsing can be expected in studies where oral hygiene is performed. [14] Unlike previous plaque associated studies on ALV, present study is the first one to follow a crossover design instead of parallel as it is more standardized and recommended method for a four day plaque re-growth study. [17] [18] [19] [20] [21] [22] A particular advantage of a crossover design is that each subject serves his or her own control so it reduces the influence of confounding that arises because of individual variables that effect plaque formation like the salivary flow and composition, existing plaque retention sites, pre-existing gingivitis, dietary habits, and the composition of pellicle. [23, 24] Also optimal crossover designs are statistically significant so require fewer subjects than non crossover design. To decrease the "carryover effect" between treatments encountered in crossover trials, a 10 day wash out period was followed in our study. Student volunteers were chosen for the current study as they are well educated, cohesive, and more sensitized to oral hygiene protocols and would understand and comply in a better way to treatment regimens.
In this study, the antiplaque action was assessed by two quantitative parameters PI and PA. We found a statistically significant difference between the plaque index scores of CHX, ALV and PM after a period of four days (Table 1) .Though the plaque reduction by ALV (PI: 3.48) was less than CHX (PI: 2.84), it nonetheless indicates that Aloe Vera can also effectively reduce experimentally induced plaque accumulation. To our knowledge there is only one previous study where the antiplaque efficacy of ALV was studied on four day plaque re-growth model; [17] but unlike ours, it wasn"t based on a crossover but on a parallel study design. The result differed from current endeavour as though ALV showed plaque reduction in their study, but a statistical significance wasn"t reached. A similar trend was also observed by Karim et al in a clinical trial conducted without abstaining daily tooth brushing. [22] These authors observed plaque reduction by ALV, but with no statistical significance. Results of clinical trials by Chandrahas et al and Villalobos et al were comparable to the present study. [18, 20] Chandrahas et al found a significant plaque score reduction by ALV, [20] however their study was based on cessation of tooth brushing only in a specified area and plaque was evaluated after seven days. Oliveria et al and Pradeep et al found a significant improvement in plaque and gingivitis score by using a dentifrice containing ALV. [19 , 21] In the current study, pattern for PA measurement was similar to PI ( Table 1 ).The mean PA for ALV (PA: 48.20%) was in between that for positive (PA: 38.16%) and negative control (PA: 55.17%).A statistically significant suppression of de novo plaque formation was shown by ALV as compared to PM (P<0.0001; Table  2 ), again suggesting that ALV does have a potential plaque inhibitory activity but less than CHX. As the present study is the first one to evaluate plaque area in a clinical trial for ALV, the results cannot be compared with the previous studies. Quirynen & Van Steenberghe considered the different plaque indices to be not exact enough and used also the plaque area calculation for a more detailed and précised analysis of plaque growth for a period of 96 hours. 25 For evaluation a planimeter was used by these authors. The area of plaque was given as a percentage of the total buccal surface just like it was done in the present study. We used a computer program to calculate the percentage of the plaque covered teeth surfaces from digital photographs similar to Söder et al. and Eaton et al. [26, 27] . Further, Renton-Harper et al. stated advantage of recording digital photographs as they are permanent records that can be re-evaluated at any point of time, and can later be transferred into other index scores; which helps in an easier comparison with other studies. [28] The plaque inhibitory potential of ALV, demonstrated in the present investigation can be attributed to its antibacterial property. The bactericidal activity of ALV is due to a numerous pharmacological active compounds including anthraquinones, alonin, aloe-emodin, aloetic acid, anthracine, aloe mannan, aloeride, antranol, chrysophanic acid, reistanol, and saponin. [29] Alonin and aloe-emodulin are the major anthraquinones in aloe plant, which have polyphenolic structures that can inhibit protein synthesis by bacterial cells;thus explaining their strong direct antibacterial and anti-inflammatory properties. [30, 31] Another component acemannan has been considered to exert an indirect bactericidal effect through stimulation of phagocytosis. [32, 33] The antimicrobial effect of ALV has been demonstrated in an in vitro study where it was reported to inhibit the growth of diverse oral microorganisms such as Streptococcus mutans, Streptococcus sanguis, Actinomyces viscosus, and Candida albicans [ . 34 ] ALV also has numerous anti-inflammatory agents like carboxypeptidase which inactivates bradykinin thereby reducing prostaglandin synthesis and inhibiting oxidation of arachidonic acid, which might decreases inflammation and relieves pain.
The response of the participants to the herbal product, as evaluated by questionnaire in the current study was good. In addition, no side effects have been noticed at the end of the study, which might add to its clinical usage as an adjunct to mechanical oral hygiene measures.
IV. Conclusion
On the basis of the results obtained, it can be concluded that ALV has a promising plaque inhibitory potential, although less than CHX. Further studies of longer duration in which antigingivitis effect can be also assessed along with evaluation of safety and microbiological parameters, are essential establish the true effectiveness of this mouthrinse. 
